AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 3.9 |
Market Cap | 4.68M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -40.4 |
PE Ratio (ttm) | -0.04 |
Forward PE | n/a |
Analyst | Hold |
Ask | 4.25 |
Volume | 16,038 |
Avg. Volume (20D) | 99,001 |
Open | 1.57 |
Previous Close | 1.71 |
Day's Range | 1.53 - 1.69 |
52-Week Range | 1.27 - 73.60 |
Beta | undefined |
About DNMR
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers....
Analyst Forecast
According to 3 analyst ratings, the average rating for DNMR stock is "Hold." The 12-month stock price forecast is $40, which is an increase of 2480.65% from the latest price.
Next Earnings Release
Analysts project revenue of $11.05M, reflecting a 0.96% YoY growth and earnings per share of -7.1, making a -54.49% decrease YoY.
2 months ago · businesswire.com
Danimer Scientific Announces Release Date for Third Quarter 2024 ResultsBAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodeg...
2 months ago · businesswire.com
Danimer Scientific Announces Intention to Complete a Reverse Stock SplitBAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or “Company”), a leading, next-generation biotechnology company focused on the production of biomaterials, announced ...